Relationship of angiotensin-converting enzyme 2 gene polymorphisms and vulnerability to coronary heart disease in patients with type 2 diabetes mellitus.
- Author:
Quan-nang YAN
1
;
Chun-sheng XU
;
Zhi-liang LI
;
Peng ZHOU
;
Ren-qing YE
;
Ming LI
;
Chao-xin JIANG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Alleles; Base Sequence; Case-Control Studies; Coronary Disease; complications; genetics; Diabetes Mellitus, Type 2; complications; genetics; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; genetics; Polymorphism, Genetic; Sequence Analysis, DNA
- From: Journal of Southern Medical University 2008;28(8):1365-1368
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms and coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM).
METHODSThis study involved 121 patients with T2DM and 94 with diabetic macroangiopathy. The polymorphisms of G8790A in ACE2 gene was analyzed using PCR-restriction fragment length polymorphism analysis in these patients, and the clinical, biochemical and echocardiographic data were also analyzed.
RESULTSNo obvious difference was found in the genotyping data between the two groups. Among the male patients with diabetic macroangiopathy, the interventricular septal end-diastolic thickness (IVSTd) were significantly greater in patients of GG genotypes of ACE2 gene G8790A than in those of AA genotypes (P<0.01), and the left ventricular mass (LVMI) and urine protein were also significantly higher in GG genotypes (P<0.05). No similar results were found the uncomplicated diabetic group or the female diabetic patients with CAD.
CONCLUSIONThe ACE2 gene G8790A polymorphism plays a role in the pathogenesis of CAD in patients with type 2 diabetes, suggesting that ACE2 genotyping is helpful to screen the susceptible patients.
